Rodríguez Antolin A, Calahorra F J, Castro M, Andrés A, Montoyo C, Praga M
Servicio de Urología, Hospital Doce de Octubre, Madrid.
Actas Urol Esp. 1990 May-Jun;14(3):188-91.
A prospective study was made of 38 adult patients (15 male and 23 female, age 30.5 +/- 10.8 years) with isolated hematuria of unknown etiology in which presence of hypercalciuria and/or hyperuricosuria without lithiasis was observed. Eighteen patients also referred episodes of macroscopic hematuria. Twenty-six patients had hypercalciuria (5.1 +/- 1.4 mg/kg/day), 29 hyperuricosuria (1053 +/- 198 mg/day) and 17 presented both alterations. A four months treatment was instituted with thiazides in patients with hypercalciuria and allopurinol in those with hyperuricosuria. From the first months and throughout the whole therapy, urinary excretion of calcium an uric acid became normalized in all cases. In 22 patients (57.8%) (Group I: Respondents) hematuria disappeared coinciding with normalization of calcium and uric acid values in urine and was maintained during the follow-up months. In the remaining 16 patients (Group II: Non-Respondents) the hematuria condition persisted in spite of such normalization, in most cases other causes for hematuria becoming clear later. No differences with regard to age, relationship male/female nor basal calciuria and uricosuria values were seen between both Groups. Group I had a greater incidence of macroscopic hematuria episodes (64% vs 12% in Group II, p less than 0.01) and of family nephrolithiasis (64 vs 25% in Group II, p less than 0.05). We conclude that hypercalciuria and hyperuticosuria are potentially reversible causes of hematuria in adults. Therefore, urinary determination of calcium and uric acid should be included in urinary evaluation of patients with hematuria even though they do not present renal lithiasis.
对38例病因不明的孤立性血尿成年患者(15例男性,23例女性,年龄30.5±10.8岁)进行了一项前瞻性研究,这些患者存在高钙尿症和/或高尿酸尿症但无结石。18例患者还出现肉眼血尿发作。26例患者有高钙尿症(5.1±1.4mg/kg/天),29例有高尿酸尿症(1053±198mg/天),17例同时出现这两种改变。对高钙尿症患者用噻嗪类药物治疗4个月,对高尿酸尿症患者用别嘌呤醇治疗。从最初几个月到整个治疗过程中,所有病例的尿钙和尿酸排泄均恢复正常。在22例患者(57.8%)(第一组:反应者)中,血尿消失,与尿钙和尿酸值恢复正常同时出现,并在随访的几个月中持续保持。在其余16例患者(第二组:无反应者)中,尽管尿钙和尿酸已恢复正常,但血尿情况仍持续存在,大多数情况下,后来血尿的其他原因变得明确。两组在年龄、男女比例以及基础尿钙和尿酸值方面均无差异。第一组肉眼血尿发作的发生率更高(64%对第二组的12%,p<0.01),家族性肾结石的发生率也更高(64%对第二组的25%,p<0.05)。我们得出结论,高钙尿症和高尿酸尿症是成人血尿的潜在可逆病因。因此,即使血尿患者没有肾结石,在尿液评估中也应包括尿钙和尿酸的测定。